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for Surgical Implants
In this issue of Chemistry & Biology, Jose and cowork-
ers [1] describe the covalent attachment of vancomycin
to a titanium surface. The tethered antibiotic is effective
against S. aureus, suggesting that this material has the
potential to complement clinical strategies for prevent-
ing infection following implant surgery.
Implant-associated infections account for approximately
50% of the estimated two million nosocomial infections
in the United States per year [2]. In orthopedic surgery,
massive implants are frequently applied, and deep wound
infection remains one of the most feared complications.
Treatment of these infections is difficult. Revision surgery
and long-term antibiotic therapy are frequently re-
quired, and an enormous burden is placed on the pa-
tient and also on health care providers, characterized
by increased rates of morbidity, mortality, poor func-
tional outcome, and prolonged hospital stays [3].
The ability of bacteria to adhere to the surface of bio-
materials and the capability of many microorganisms
to form biofilms on foreign body materials are crucial
steps in the pathogenesis of implant-related infections
[4–6]. By biofilm formation, bacteria become protected
against host immune defense mechanisms and de-
velop a marked increase in resistance toward antibiot-
ics [4, 7–9].
With respect to the magnitude of the clinical problem,
prophylaxis of deep wound infection is of major impor-
tance. In orthopedics, the rate of infection could signifi-
cantly be reduced by strictly aseptic conditions, atrau-
matic surgical techniques, shortening of operation
time, and the application of systemic antibiotic prophy-
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saxis [10, 11]. “Bioactive, self-protecting” implants are
ttractive additions to these approaches and could
upplement the standard methods of prophylaxis.
An interesting effort to develop these types of im-
lants is introduced by Jose et al. [1] in this issue of
hemistry & Biology. The authors modified Ti-OH on
he outer surface of titanium beads with 3-aminopro-
yltriethoxysilane. Aminoethoxyethoxyacetate linkers
ere interposed before vancomycin was covalently
oupled to the surface, thus ensuring a proper distance
rom vancomycin to the implant’s surface, in order to
llow the antibiotic to interfere with the biosynthesis of
he bacterial cell wall. The authors showed that vanco-
ycin bonded to titanium beads was still able to bind
pecifically to its target, a bacterial petidoglycan li-
and. Further, a significant reduction of Staphylococ-
us aureus could be shown after incubation in vitro.
At present, prophylaxis is mainly performed by local
rug delivery systems. Predominantly, antibiotics are
eleased from polymethylmethacrylate beads, various
ypes of bone cement or collagen sponges. Their use
s efficient, and high local drug levels can be achieved
o protect the implant from being colonized. However,
he drug carriers themselves can cause allergic and for-
ign body immune reactions. Moreover, some of them
re not biodegradable and need to be surgically re-
oved. Improper release kinetics of antibiotics (e.g.,
ong-term liberation over years with suboptimal tissue
evels from bone cement) may evoke the development
f resistant bacterial strains.
Another method for implant protection utilizes a thin
about 10 m thick), biodegradable, and mechanically
obust poly(D,L)-lactide coating of implants that was
ccepted by Europe and Canada in 2005. This coating
s loaded with gentamicin and is suitable to envelope
tainless steel and titanium implants [12]. The antibiotic
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959is released with an initial burst over a limited time of
4–6 weeks, and the carrier completely dissolves within
4–6 months. Thus, high local levels of gentamicin can
be achieved at the interface for a limited time.
Providing another potential treatment option, promis-
ing aspects of the presented work [1] include covalent
bonding of a clinically relevant antibiotic to titanium,
which is the most favored material for metallic implants
in the field of orthopedics. Thus, it may be assumed
that this component will suit the mechanical demands
of bone surgery. As the antibiotic is tightly connected
to the implant and not released into the surrounding
tissue, development of vancomycin-resistant mutant
bacteria is rather unlikely. Besides, long-term protec-
tion of the implant may be expected as the antibiotic
resides within its microenvironment and thus might pre-
vent bacterial adhesion and subsequent colonization.
The presented work is of clinical relevance. Hypothe-
sizing that implant-related infection is mainly caused by
incorporated bacteria during surgery, the interface of
tissue and implant is the most important target for pro-
phylaxis. Despite strictly aseptic conditions, appropri-
ate surgical techniques, and systemic application of
antibiotics, an additional local prophylaxis appears rea-
sonable. The presented modification of titanium im-
plants is a new approach and could supplement the
present strategies.
Looking to the future, questions concerning the me-
chanical properties, long-term stability, and in vivo in-
tegrity of the modified surface should be answered.
Considering the promising results in vitro, in vivo test-
ing with a suitable animal model of implant-related os-
teomyelitis would be of great interest [13].Martin Lucke
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Augustenburger Platz 1
13353 Berlin
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